New York, NY -- (SBWIRE) -- 01/17/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Dendreon Corporation(NASDAQ:DNDN), EXCO Resources Inc(NYSE:XCO), Kinross Gold Corporation (USA)(NYSE:KGC),Geron Corporation(NASDAQ:GERN)
Dendreon Corporation(NASDAQ:DNDN) reported loss -6.341% and closed at $3.12 with the total traded volume of 5.76M shares. Its market capitalization is $491.36M. The stock has a 52-week high price of 7.22 and its 52-week low was recorded at $2.23.
Dendreon Corporation (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that may significantly improve cancer treatment options for patients.
What DNDN Charts Are Signaling for Traders? Find Out Here
EXCO Resources Inc(NYSE:XCO) loss -0.84% and ended at $4.74.The total traded volume was 5.71M shares and market capitalization arrived at $1.03B. The stock has a 52-week high price of $9.00 and its 52-week low was recorded at $4.65, while during last trade its minimum price was $4.65 and it gained the highest price of $4.85.
EXCO Resources, Inc. (EXCO Resources) is an independent oil and natural gas company engaged in the exploration, exploitation, development and production of onshore the United States oil and natural gas properties with a focus on shale resource plays.
Is XCO Buy After The Recent Price Movement? Find Out Here
Kinross Gold Corporation (USA)(NYSE:KGC)’s reported the gain 0.89% to close at $4.54 with the overall traded volume of 5.70M shares. Its market capitalization on last close reached to $5.19 billion. Its intraday-low price was $4.48 and its hit its day's highest price at $4.57.
Kinross Gold Corporation (Kinross) is engaged in gold mining and related activities, including exploration and acquisition of gold-bearing properties, the extraction and processing of gold-containing ore, and reclamation of gold mining properties.
Should KGC a Buy or Sell Now? Find Out Here
Geron Corporation(NASDAQ:GERN) loss -5.33% settle at $4.26. Its total traded volume during last trading session was 5.57M shares. The overall market worth of this company is about $549.40M. The 52 week range of the stock remained $0.98- $7.79, while its day's lowest price was $4.08 and its hit its day's highest price at $4.38.
Geron Corporation (Geron) is a clinical-stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
What GERN Charts Are Signaling for Traders? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)